Uni Eropa - Sloven - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologija za aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Uni Eropa - Sloven - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - prašiči - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Uni Eropa - Sloven - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - debelost - preparati za zaščito proti sončenju, prehrambeni izdelki - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Slovenia - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cinkov sulfat; glicin; glukoza; histidin; kalcijev klorid; alanin; arginin; fenilalanin; izolevcin; levcin; lizin; metionin; prolin; serin; tirozin; treonin; triptofan; valin; magnezijev sulfat; natrijev acetat; ribje olje, bogato z omega-3-kislinami; sojino olje, prečiščeno; trigliceridi, srednjeverižni; tavrin; kalijev klorid; olivno olje, prečiščeno; olivno olje, prečiščeno; natrijev glicerolfosfat - emulzija za infundiranje - cinkov sulfat 0,0032 g / 1000 ml  glicin2,8 g / 1000 ml  glukoza68 g / 1000 ml  histidin0,75 g / 1000 ml  kalcijev klorid0,14 g / 1000 ml  alanin3,5 g / 1000 ml  arginin3 g / 1000 ml  fenilalanin1,3 g / 1000 ml  izolevcin1,3 g / 1000 ml  levcin1,9 g / 1000 ml  lizin1,7 g / 1000 ml  metionin1,1 g / 1000 ml  prolin2,8 g / 1000 ml  serin1,6 g / 1000 ml  tirozin0,1 g / 1000 ml  treonin1,1 g / 1000 ml  triptofan0,5 g / 1000 ml  valin1,6 g / 1000 ml  magnezijev sulfat0,3 g / 1000 ml  natrijev acetat0,85 g / 1000 ml  ribje olje, bogato z omega-3-kislinami5,3 g / 1000 ml  sojino olje, prečiščeno11 g / 1000 ml  trigliceridi, srednjeverižni11 g / 1000 ml  tavrin0,25 g / 1000 ml  kalijev klorid1,11 g / 1000 ml  olivno olje, prečiščeno8,8 g / 1000 ml  olivno olje, prečiščeno8,8 g / 1000 ml  natrijev glicerolfosfat1 g / 1000 ml; glicin 2,8 g / 1000 ml  glukoza68 g / 1000 ml  histidin0,75 g / 1000 ml  kalcijev klorid0,14 g / 1000 ml  alanin3,5 g / 1000 ml  arginin3 g / 1000 ml  fenilalanin1,3 g / 1000 ml  izolevcin1,3 g / 1000 ml  levcin1,9 g / 1000 ml  lizin1,7 g / 1000 ml  metionin1,1 g / 1000 ml  prolin2,8 g / 1000 ml  serin1,6 g / 1000 ml  tirozin0,1 g / 1000 ml  treonin1,1 g / 1000 ml  triptofan0,5 g / 1000 ml  valin1,6 g / 1000 ml  magnezijev sulfat0,3 g / 1000 ml  natrijev acetat0,85 g / 1000 ml  ribje olje, bogato z omega-3-kislinami5,3 g / 1000 ml  sojino olje, prečiščeno11 g / 1000 ml  trigliceridi, srednjeverižni11 g / 1000 ml  tavrin0,25 g / 1000 ml  kalijev klorid1,11 g / 1000 ml  olivno olje, prečiščeno8,8 g / 1000 ml  olivno olje, prečiščeno8,8 g / 1000 ml  natrijev glicerolfosfat1 g / 1000 ml; glukoza 68 g / 1000 ml  histidin0,75 g / 1000 ml  kalcijev klorid0,14 g / 1000 ml  alan - kombinacije

Uni Eropa - Sloven - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - multiplo sklerozo, recidivno-nakazila - imunosupresivi - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Uni Eropa - Sloven - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirusi za sistemsko uporabo - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 in 5. tecovirimat siga should be used in accordance with official recommendations.

Uni Eropa - Sloven - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - druga zdravila na živčnem sistemu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Uni Eropa - Sloven - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukemija, myeloid - antineoplastična sredstva - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Slovenia - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

prašek za peroralno raztopino - hranila brez fenilalanina

Slovenia - Sloven - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kemofarmacija d.d. - fenobarbital - tableta - fenobarbital 100 mg / 1 tableta - fenobarbital